BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Valensa International, LLC Receives Five US Patent Approvals on GoEasy™ Gastrointestinal Health Formula


3/7/2013 11:03:03 AM

ORLANDO, Fla., March 7, 2013 /PRNewswire/ -- Valensa announced today that it has received five new US patents on its GoEasy Gastrointestinal Health Formula. GoEasy Gastrointestinal Health Formula is a unique micro-dispersion of natural, plant-based, non-GMO policosanols in a stabilized mixture of plant-based Omega-3 extracts. Regular use of the Formula helps maintain gastrointestinal (GI) health by supporting regularity via mild lubrication of the GI tract - without the unpleasant side effects of traditional laxatives or fiber-based products. A pre-clinical study showed a reduction of cholesterol by up to 15% in test subjects and an increase in the average weekly number of normal bowel movements in subjects suffering from poor GI track function. The cholesterol reduction observed during the trial has been attributed to blocking of the well-known cholesterol re-uptake mechanism in people who have infrequent bowel movements, along with the mild laxative effects of ALA-rich plant-based Omega-3 oils. The patents relate to the composition and use of the Formula in maintaining healthy gastrointestinal function while improving lipid health. The Formula is recommended for daily use as a dietary supplement for individuals who do not receive enough natural dietary waxes and Omega-3's from greens, fruits and vegetables in their diet.

According to Dr. Rudi E. Moerck, President and CEO of Valensa, GoEasy Gastrointestinal Health Formula helps restore a natural functional balance to diets of people who increasingly consume excessive amounts of non-functional processed foods. "Our bodies function best with diets that have plenty of leafy green vegetables and fruits all of which contain botanical waxes, or policosanols, in abundance. When we forget to eat them, or over-indulge in processed foods, we lose the natural waxes and our intestinal function suffers. Go Easy is a safe and elegant approach to restoring natural waxes in our diets," he said. "The combination of all-natural policosanols and heart-healthy plant based Omega-3's found in GoEasy offers very safe and very mild efficacy without the harshness of chemical laxatives or the gas and bloating commonly associated with using fiber-based products to maintain regularity. Because it works by a totally different mechanism, GoEasy Gastrointestinal Health Formula is safe to consume with a high fiber diet," he added.

GoEasy Gastrointestinal Health Formula is a small easy-to-swallow softgel that can be taken once or twice daily. The Formula features a patent-protected micro-dispersion technology which distributes small sized particles of policosanols in a heart-healthy oil. The new formula also features Valensa's O2B Peroxidation Blocker technology for protection from rancidity and a shelf-life of 2 years at 25o C.

According to Moerck, with the formulating technology used for GoEasy Gastrointestinal Health Formula, Valensa has unlocked the mystery behind policosanol's potential for the supplement market. "Early work with policosanols showed cholesterol-lowering potential, but subsequent trials that focused on absorption couldn't reproduce initial trial results. What we have found is that policosanols are not systematically absorbed due to their very high molecular weights. Instead, they have a 'ball-bearing' effect on the food bolus in the body, helping to maintain proper movement through our GI track. Our work with micro-dispersion technology and formulating with Omega-3s has demonstrated efficacy and resulted in these patents," he said.

For further information contact:
Dr. Rudi Moerck, President & CEO
Voice: 352-357-2004 ext. 701
www.valensa.com

This press release was issued through eReleasesĀ® Press Release Distribution. For more information, visit http://www.ereleases.com.

SOURCE Valensa



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES